Open access · CC-BY
via OpenAlex
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
Kerstin Iffland, Franjo Grotenhermen
Cannabis and Cannabinoid Research · 2017 · ▲ 630 citations
Abstract
Introduction: This literature survey aims to extend the comprehensive survey performed by Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from updating the literature, this article focuses on clinical studies and CBD potential interactions with other drugs. Results: In general, the often described favorable safety profile of CBD in humans was confirmed and extended by the reviewed research. The majority of studies were performed for treatment of epilepsy and psychotic disorders. Here, the most commonly reported side effects were tiredness, diarrhea, and changes of appetite/weight. In comparison with other drugs, used for the treatment of these medical conditions, CBD has a better side effect profile. This could improve patients' compliance and adherence to treatment. CBD is often used as adjunct therapy. Therefore, more clinical research is warranted on CBD action on hepatic enzymes, drug transporters, and interactions with other drugs and to see if this mainly leads to positive or negative effects, for example, reducing the needed clobazam doses in epilepsy and therefore clobazam's side effects. Conclusion: This review also illustrates that some important toxicological parameters are yet to be studied, for example, if CBD has an effect on hormones. Additionally, more clinical trials with a greater number of participants and longer chronic CBD administration are still lacking.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1089/can.2016.0034
- Canonical
- link ↗
- Fetched
- 2026-06-08 MST
Cite this
APA
Iffland, K., & Grotenhermen, F. (2017). An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. <em>Cannabis and Cannabinoid Research</em>. https://doi.org/10.1089/can.2016.0034
Vancouver
Iffland K, Grotenhermen F. An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. Cannabis and Cannabinoid Research. 2017. doi:10.1089/can.2016.0034.
BibTeX
@article{kerstin2017AnUpda,
title = {An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies},
author = {Kerstin Iffland and Franjo Grotenhermen},
journal = {Cannabis and Cannabinoid Research},
year = {2017},
doi = {10.1089/can.2016.0034},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Royal College of Surgeons, Ireland 2025
Open access · US-GOV
Multicomponent Exercise and Nutrition Based Frailty Intervention in Postoperative Hip Fracture Inpatients
Expert Opinion on Therapeutic Targets 2024
Citation only
Candidate molecular targets uncovered in mouse lifespan extension studies
Landspitali University Hospital 2015
Open access · US-GOV
EEG-cholinergic Index and Its Validation of Clinical Response to Treatment With Cholinesterase Inhibitors
Journal of Internal Medicine 2024
Open access · CC-BY
Delirium and frailty in older adults: Clinical overlap and biological underpinnings
Nephrology Dialysis Transplantation 2018
Citation only
FP115KIDNEY BIOPSY IN THE ELDERLY: FRAILTY INDEX IS A GOOD TOOL TO PREDICT CLINICAL OUTCOMES
International Journal of Molecular Sciences 2023
Open access · CC-BY